Day One Biopharmaceuticals Stock Jumps on Renewed M&A Rumors
Day One Biopharmaceuticals shares surge 26% to $12.62 amid fresh speculation of a potential buyout.
Already have an account? Sign in.
Day One Biopharmaceuticals shares surge 26% to $12.62 amid fresh speculation of a potential buyout.
Zillow and Redfin settle FTC lawsuit over $100M deal. Redfin must relaunch ads in 6 months; partnership continues through 2030.
Court orders Guardant Health to pay over $245.2M for willfully infringing TwinStrand’s DNA sequencing patents. Ongoing 6% royalties apply; Guardant will appeal.
Evercore lifts Expedia’s PT to $430 (from $375); Wedbush raises its target to $417 (from $334) following the Q2 earnings beat and raised guidance.